Uncovering the mechanisms of Acinetobacter baumannii virulence.
Harding CM, Hennon SW, Feldman MF.
Nat Rev Microbiol. 2018 Feb;16(2):91-102. doi: 10.1038/nrmicro.2017.148. Epub 2017 Dec 18.
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options.
Lee CR, Lee JH, Park M, Park KS, Bae IK, Kim YB, Cha CJ, Jeong BC, Lee SH.
Front Cell Infect Microbiol. 2017 Mar 13;7:55. doi: 10.3389/fcimb.2017.00055. eCollection 2017.
An overview of Acinetobacter baumannii pathogenesis: Motility, adherence and biofilm formation.
Mea HJ, Yong PVC, Wong EH.
Microbiol Res. 2021 Jun;247:126722. doi: 10.1016/j.micres.2021.126722. Epub 2021 Feb 4.
Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.
Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B.
Clin Microbiol Rev. 2017 Jan;30(1):409-447. doi: 10.1128/CMR.00058-16.
The multifaceted genus Acinetobacter: from infection to bioremediation.
Dahal U, Paul K, Gupta S.
J Appl Microbiol. 2023 Aug 1;134(8):lxad145. doi: 10.1093/jambio/lxad145.
Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features.
Bergogne-Bérézin E, Towner KJ.
Clin Microbiol Rev. 1996 Apr;9(2):148-65. doi: 10.1128/CMR.9.2.148.
Acinetobacter infection in the ICU.
Murray CK, Hospenthal DR.
Crit Care Clin. 2008 Apr;24(2):237-48, vii. doi: 10.1016/j.ccc.2007.12.005.
Treating multidrug-resistant Acinetobacter baumannii infection by blocking its virulence factors.
López-Rojas R, Smani Y, Pachón J.
Expert Rev Anti Infect Ther. 2013 Mar;11(3):231-3. doi: 10.1586/eri.13.11.
Acinetobacter infection--an emerging threat to human health.
Visca P, Seifert H, Towner KJ.
IUBMB Life. 2011 Dec;63(12):1048-54. doi: 10.1002/iub.534. Epub 2011 Oct 18.
Acinetobacter lwoffii infection and gastritis.
Rathinavelu S, Zavros Y, Merchant JL.
Microbes Infect. 2003 Jun;5(7):651-7. doi: 10.1016/s1286-4579(03)00099-6.
